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Obesity is often established in adolescence, and
advances are being made in identifying its ge-
netic underpinnings. We examine issues related
to the eventual likelihood of genetic tests for
obesity targeted to adolescents: family involve-
ment; comprehension of the test’s meaning; how
knowledge of genetic status may affect psycho-
logical adaptation; minors’ ability to control
events; parental/child autonomy; ability to make
informed medical decisions; self-esteem; unclear
distinctions between early/late onset for this con-
dition; and social stigmatization. The public
health arena will be important in educating fami-
lies about possible future genetic tests for obe-
sity.
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Introduction
Categorizing Obesity as a Biobehavioral Trait
Advances in behavioral genetics point to the importance
of biologic inheritance in behavioral traits as well as in
medical conditions. Examples of the latter include dis-
eases such as Huntington’s disease, cystic fibrosis,
Down’s syndrome, and many others in which, when
known genetic variants are present, it is almost certain
that the affected individuals will develop the conditions.
Other diseases, including breast and other cancers, are in
some individuals the result of genetic variants interacting
with environmental factors. This is necessarily a question
of degree: nearly all disease in some sense results from
the interaction of genetic variation and the environment.1
Although individuals affected with these diseases
may experience guilt and stigmatization, society does not
usually fault them directly for contracting them. It is
generally recognized that a person with Huntington’s
disease does not do anything to acquire the condition—
having parents who are carriers is necessary and suffi-
cient. Similarly, breast and other cancers are generally
viewed as resulting from either genetic inheritance or
external forces, e.g., environmental toxins, outside the
individual and largely beyond his or her control (al-
though there are claims that eating this kind of food or
avoiding that kind of environment may help to prevent
cancer).
These conditions are distinct from those we call
“biobehavioral” traits, which are perceived to be under
the voluntary control of the individual and include alco-
hol abuse and addiction; some psychiatric conditions
such as depression; obesity; and smoking addiction.
Behavior associated with these traits leads to the assump-
tion, in many people’s minds, that the affected individ-
uals have personal responsibility for their conditions.2
However, recent laboratory advances suggest that biobe-
havioral traits have a strong genetic substrate.
We are particularly interested in obesity because it is
widespread and implicated in many preventable diseases
in the United States.3 Adolescence appears to be a
critical period in developing obesity, and so obesity
genetic testing may be targeted to this age group.
Medical Problems Associated with Obesity
Obesity is a serious and growing health care problem in
the United States.4,5 We use federal guidelines identify-
ing body mass index (BMI) 25 to 30 as overweight,
and 30 as obese (BMI is calculated as kg/m2). The
condition is a precursor for many health problems, in-
cluding diabetes,6 cardiovascular disease, hypertension,
hypercholesterolemia, gallbladder disease, osteoarthritis,
some cancers,7–10 and stroke.11 As many as one-third of
U.S. adults (59 million) are estimated to be overweight
or obese,12,13 and prevalence is increasing: from 1991 to
1999, it is estimated conservatively that the prevalence of
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obesity in the United States increased by 58%.14,15 Prev-
alence among younger adults 18 to 29 years old is
especially notable, increasing 70% from 1991 to 1998,
from 7.1% to 12.1%.14 In youths, the increase in obesity
is equally alarming: approximately 11% are seriously
overweight and an additional 14% are at risk for over-
weight.16 Obesity is now one of the most serious and
rapidly worsening health problems of youth in the United
States,17,18 and obesity-related diseases are increasing in
younger people.12,19 In long-term follow-up, boys’ obe-
sity in adolescence leads to increased mortality in later
life relative to lean peers,20,21 even if weight at age 50 is
statistically controlled.22 Obesity is remarkably resistant
to behavioral treatment: up to 90% to 95% of those who
lose weight return to their previous obese state.23–25 Late
adolescence appears to be a critical period in the devel-
opment of obesity that persists into later life.26
Progress in Identifying Genetic Underpinnings
The importance of environmental factors in obesity is
clear,27–29 but the importance of physiologic factors in
metabolism has also been confirmed; for example, a
recent report showed that obese adolescents consume no
more “junk food” than non-obese adolescents.30 Genetic
factors are shown in studies of twins, familial aggrega-
tion, and adoptees whose weight correlates more closely
with their biologic rather than adopted families.31,32 Half
of the variance in the amount of abdominal visceral fat,
which is believed to confer greater health risk than other
types of fat, is possibly determined by a single gene in
some populations, whereas 21% may be determined by
more than one,33,34 and 40% to 80% of the variance in
body weight is due to genetic factors.35,36 Many scien-
tists assert that it is only a matter of time until tests are
available for genes that contain DNA sequence variants
that predispose people to develop obesity.12 Five genes
responsible for obesity in humans have been described:
leptin,37 leptin receptor, prohormone convertase 1 (PC1),
and pro-opiomelanocortin (POMC), all of which are
associated with hypothalamic and pituitary disorders,
and the melanocortin-4 receptor (MC4-R),38 which
causes a non-syndromic phenotype of morbid obesity.
Recently, another gene has been identified that is asso-
ciated with a relatively mild obesity.39 A fairly large
number of genetic markers are likely involved in most
cases, each coding for a specific propensity for a partic-
ular metabolic effect.40 The implications for genetic
testing are clear: “If some environmental variables man-
ifest themselves only on certain genotypes, efforts to
prevent obesity at a public health level can be focused on
recognition and counseling of susceptible individu-
als. . . . In addition, appreciating the importance of ge-
netic variation as an underlying cause helps to dispel the
notion that obesity represents an individual defect in
behavior with no biological basis . . .”31
Genetic Testing of Adolescents for Obesity
We first review the relevant issues in genetic testing
generally, followed by genetic testing for minors, and
then possible future genetic testing for obesity in minors.
We then discuss approaches to future genetic testing for
obesity, particularly in minors, suggested by the review.
General issues in genetic testing relevant to adoles-
cents include the involvement of the entire family, dif-
ficulty in understanding the meaning of genetic variants
and genetic risk, and our incomplete understanding of
how knowledge of genetic status affects health behavior
and psychological adaptation.
Relevance to Biologic Relatives
A key aspect of genetic testing that is often said to set it
apart from other laboratory procedures is that the infor-
mation an individual receives about a genetic test has
implications for biologic relatives, especially close ones.
Patients sometimes decide to withhold results from fam-
ily members.41–44 When is it appropriate to notify other
family members of results of a genetic test? Is it ever
morally defensible, or imperative, not to notify members
under certain circumstances, e.g., if the family member is
emotionally fragile and there is no known treatment or
cure? Of course, families are often involved when a
member receives any kind of diagnosis or laboratory
result, and, even if it does not have direct implications
for the physical health of other members, it may well
influence their future financial resources and/or their
psychological well-being. In the case of genetic tests for
obesity, however, which would not signal imminent
danger to relatives, there seems to be less reason to
reveal test results to other relatives; indeed, it could be
seen as a betrayal for a parent to reveal an adolescent’s
test results to others.
Comprehension of the Meaning of a Genetic
Test for Risk
The difficulty of conveying the significance of a genetic
test result is particularly acute in the case of polygenic
traits of low penetrance, e.g., cancer, in which affected
genetic status leads to an increased risk, but far from
absolute certainty, that the individual will have the dis-
ease. This may well be the situation for obesity. (There
are infrequently occurring exceptions—for example, in-
dividuals affected with congenital leptin deficiency have
a monogenic variation that clearly results in obesity.)
Public understanding of risk and probability state-
ments is limited.45,46 Even highly educated adults have
difficulty using mathematical operations concerning
probabilities,47 and scientific illiteracy is widespread.48
The concept of lifetime risk is poorly understood, and so
is the idea that demographic factors modify average
risk.49 More research is needed on numeracy and optimal
methods for presenting risk estimates.50
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Subtle language and framing effects often operate,
e.g., whether risks are presented as relative or absolute,51
rates or proportions,52 framed as loss or gain,53 or
whether subjects are asked whether they would “accept”
or “risk” adverse medical situations.54 Even after coun-
seling, many patients fail to recall genetic risk figures
accurately.55–57
How Knowledge of Genetic Status Affects
Health Behavior and Psychological Adaptation
A growing literature documents the public’s attitudes
about and perceptions of genetic testing, including
tradeoffs in perceived benefits and disadvantages58,59
and psychological aspects60,61 for adult-onset disorders
in general,62 and for specific diseases such as breast and
ovarian cancer,63 colorectal cancer,64,65 prostate can-
cer,66,67 cystic fibrosis,68 and Huntington’s disease.69 Of
course, the applicability of these studies regarding obe-
sity is questionable. Some studies have found psycho-
logical effects of reassurance; others of anxiety and
depression.70 In general, perceived benefits are stress
reduction from uncertainty,71 ability to plan, and relief
for those who test negative. Many appreciate the in-
creased knowledge of genetic risk. Disadvantages of a
negative result may include a sense of guilt in some
members of affected families.72 Perceived disadvantages
for those who test positive, in addition to the obvious
health-related issues, are possible discrimination by em-
ployers73 and the inability to obtain life and health
insurance.74
Studies on genetic testing for breast or ovarian
cancer75 and for Huntington’s disease76 suggest that the
psychological benefits may outweigh the risks, although
there are concerns that genetic information may generate
psychological distress.77,78 The stigma associated with
breast cancer diagnosis has been found to decrease test-
ing interest.79 However, obesity is a seriously stigmatiz-
ing condition because of its implications about poor
personal character, and so the possibility that it is genet-
ically influenced may reassure some people and allay
their anxiety. Little is known about how people perceive
evidence for a genetic basis for behavioral conditions.
For some, a positive genetic test result may be reassuring
because it alleviates the burden of individual responsi-
bility, while for others it may be troubling precisely
because it seems to diminish their control.
It is also unclear how self-awareness of genetic
status might affect health care behavior, e.g., treatment,
screening, and prevention efforts. Might patients who
discover a genetic propensity feel more motivated to
avoid overeating, or might feelings of hopelessness over-
whelm them and negatively affect their desire for self-
control?80
Genetic Testing of Minors
Advantages and Disadvantages Specific to
Minors
Adolescents often need to believe that they have explicit
control in order to adjust well to life problems.81 Some
children may be aware of problems in families with
genetic conditions, including the possibility that they are
at risk, but may feel unable to express their anxieties and
concerns.82 An investigation of Canadian high schoolers’
attitudes towards cystic fibrosis screening found that,
given the chance to participate, many viewed the expe-
rience positively.83 As for adults, advantages of genetic
testing for minor children may include resulting freedom
from anxiety and lead to more open discussion of the
problem. Also, parents may feel better equipped to take
the genetic factors into account as they try to secure the
best environment they can for the child and for the whole
family.84
On the other hand, those opposed to testing children
focus on how the genetic testing deprives them of mak-
ing an informed choice when they reach adulthood about
whether they wish to be tested. For some conditions,
adults do not wish to be tested, and adolescents tend not
to look beyond the immediate situation and not to rec-
ognize that their values may change over time.85,86 As is
the case for adults, there may be negative consequences
for a child because of discrimination and stigmatization
from others because of the inherited condition.
Perhaps more subtle and more devastating, parents’
expectations of and behavior toward a child with the
genetic variant may change for the worse,81 perhaps even
resulting in the parents “scapegoating” the child. The
reaction of parents when told the results of their chil-
dren’s genetic tests, e.g., for early-onset cancer, is in-
structive: positive tests increased anxiety, and parents of
children with negative results were not reassured.87
Genetic disease can be a source of “enormous per-
sonal and family shame and guilt . . . diminished self-
esteem, feelings of deficiency and loss of control follow-
ing birth of a child with a genetic disorder.”88 How could
this play out in a condition as different from cancer as
obesity? The order of magnitude might of course be
different; however, knowledge that a child is a carrier for
obesity genes might lead some well-meaning parents to
restrict the child’s eating excessively, similar to the
harshly restrictive diets that some children found to have
above average serum cholesterol have been fed.81 Chil-
dren who receive a negative genetic test result for a
medical condition may experience survivor guilt,82,86
especially if the condition affects siblings. There is the
possibility of being socially ostracized because parents
and siblings may perceive them as different.89,90 In the
case of obesity, they may also experience frustration
because of the lack of a genetic cause to blame.
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Data are limited, but some authors have explored the
reactions of children to screening for risk factors. In
pediatric screening for a predictor of diabetes, children
who tested positive were anxious when first told, but
their anxiety returned to normal within 2 to 3 months;
apparently, the children minimized the health threat,
although relatives did not.91 Children who learned the
results, whether positive or negative, of their genetic
testing for hereditary colorectal cancer did not show
significant changes in depression or anxiety scores over
a several-year period of follow-up,92,93 although a sub-
sample of children with mutation-positive siblings had
higher, although subclinical, depression scores.93
Should Parents Be Final Arbiters, or Should
There Be Some Public Consensus about
Genetic Testing of Minors?
The issue of respect for a child’s autonomy versus
beneficence for his or her welfare is central to the
discussion about parental and child decision-making
about genetic testing. There is an increasing emphasis
today in the medical profession on patients’ decision-
making, with information and guidance from their phy-
sicians. This emphasis on autonomy has encouraged
increasing participation by children as well as adults in
health care decisions. Authors in the critical care litera-
ture have called for physicians to consider consulting
adolescent patients about the direction of their care,
rather than relying solely on parents or guardians. This
trend is fostered by an increasing respect for the child’s
capacity to make medical decisions.91,94,95 However, in
medical issues for children in general, and in genetic
issues in particular, an important question concerns the
autonomy of the adult (parent) as well as the child.86
There appears to be an impasse involving the value
judgments at the heart of decisions about testing children
for various adult-onset conditions. Some authors believe
strongly that these kinds of decisions “should be made by
those who care most about the children—the parents,”82
and researchers have described parents’ frustration when
they have been denied breast cancer genetic testing for
their minor children.96 Indeed, some suggest that if
parents are anxious about a child, the reduction of this
anxiety through testing may benefit not only themselves
but also the entire family, including the tested child and
siblings. So this reduction of parental anxiety in itself
might be sufficient reason to test the child.
What if parents and minor children disagree? Some
believe that both the parents and adolescent must consent
to testing if there is no therapeutic intervention that can
begin in childhood.97 However, there is the potential for
undue parental influence over minors in medical deci-
sions.98 Others have suggested that in some circum-
stances, the wishes of an adolescent to participate in or
refrain from testing might override parental wishes, e.g.,
for an allele that is a risk factor for the severity of
consequences of head trauma that might be sustained
during high-contact sports.99 This situation seems anal-
ogous to obesity in that the adolescent’s decisions about
present-day behavior might cause later problems. How-
ever, some public health experts believe that testing
decisions involve values and thus are decisions that
concern society as a whole,100 and not just any single
group of stakeholders. Testing minors is potentially dan-
gerous for their social adjustment and access to insur-
ance, and could be an invasion of their privacy.
Furthermore, there is no consensus among profes-
sionals about if and when to test minors, so suggestions
to leave the decisions to health care providers would not
be useful. Geneticists in the United States are less willing
to test children than are pediatricians and parents.85,86 In
one study, half of surveyed geneticists, but three-quarters
of pediatricians, would test for a genetic predisposition to
alcoholism if such a test existed, although they would not
necessarily share results with the children until the age of
majority.
Geneticists and pediatricians were also surveyed
about whether a 16-year-old should be able to refuse
genetic testing in spite of the parent’s desire for the child
to be tested. If the condition were treatable, only 28% of
pediatricians and 22% of geneticists would honor the
minor’s wishes to refrain. If not treatable, however, more
geneticists would wish to withhold the testing.
Existing research has only begun to focus on these
issues. Michie and Marteau91 noted that we need to
examine more closely the attitudes of children, parents,
and health professionals; the informed consent process
and how communication leads to information recall and
decision-making; and the psychological consequences of
predictive testing in children, particularly when they are
members of families at risk.
Should Age or Competency Be the Criterion?
Age
A number of studies have examined how age influences
children’s development of the kinds of abilities that are
required for informed decision-making about genetic
testing. Informed consent for research is required for
those 18 years and older; children as young as 7 years are
sometimes considered capable of assent, defined as “a
child’s affirmative agreement to participate in re-
search.”101 However, there are no clear guidelines for
obtaining assent for different ages and abilities of young
children.102
Piaget’s work suggested that children enter the stage
of formal operations and abstract thought at about age
12. Although his work has been criticized as insuffi-
ciently sensitive to factors such as social class, income,
ethnicity, number of children in the family, parents’ ages
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and education, and other home aspects103—all of which
can produce variation in the age at which formal opera-
tions are undertaken—11 or 12 years is the age when
children are considered capable in many religious tradi-
tions of major decisions.85 Research that compared chil-
dren’s perceptions of their understanding of elements of
research consent with their actual measured levels of
understanding suggested that those older than 11 years
had significantly greater understanding than younger
children.104
Some authors point out that early adolescence is the
time at which understanding and maturity begin.105 Ad-
olescents 12 to 14 years old appear less able to perform
the required activities, such as anticipating consequences
and recognizing vested interests in communication, than
those around the age of 15.106 The courts have ruled that
minors can consent independently to medical treatment
at age 15.86 While some have suggested that 14-year-
olds appear to have levels of mental competence com-
parable to adults regarding decision-making about med-
ical treatment in general,107,108 social concepts and
motivational aspects appear somewhat later, in those 15
and older.106 In a recent study, more than 70% of
early-onset breast cancer survivors believed that the
appropriate age for informing children about the familial
possibility of hereditary breast cancer risk was before
18.109 When children and adolescents themselves were
asked about the age at which they should be allowed to
make medical decisions, the average response was in the
range of 15 to 16.6 years.110,111 But some experts have
noted that decisions to test 16-year-olds should take into
account issues of personal identity, sexuality, and family
relationships that adolescents are dealing with at that
age.91
Competency
Development of criteria for informed decision-making
by adolescents may be approached by focusing not on
the age at which certain competencies appear, which
must be variable, but on the sources of such cognitive,
psychological, and social variability. Each case could
then be specifically evaluated for these competencies.
Competency has been defined as understanding relevant
information, having the wisdom or discretion to evaluate
it in light of one’s best interests, and having the confi-
dence to act with some independence and to take respon-
sibility and accept blame. Assessment of competency
will be difficult without clearly agreed upon methods.112
Because few adults have these capacities, authors
have pointed out that higher standards should not be
expected of children.112 Processes used by adults fall far
short of normative rational decision-making, and are
subject to the kinds of biases found in situations marked
by uncertainty.111,113 Thus, adolescents’ processes may
not be noticeably worse than those of adults. However, a
recent review of the relatively few studies available
suggested that adolescents’ decision-making competence
in general may be less than adults in some areas, such as
advice-seeking and goal setting, but similar to adults in
other areas, such as response to moderating factors.114
Children age 10 to 17 who were interviewed about
participating in research involving genetic testing for
breast cancer and heart disease initially viewed the re-
search as low risk before they received counseling about
the hazards,115 yet adults often have similar reactions.
Variables that should be taken into account in describing
these processes include112:
● Knowledge of relevant condition based on personal
experience. Children who have lived with a relative
who has the medical condition may have a better
grasp of the issues than children who may be cog-
nitively more advanced but cannot personalize the
information to the same extent.112
● Family pressure applied to the child regarding test-
ing.116 Pressure from parents or other family mem-
bers may compromise a child’s ability to look at the
cognitive issues clearly. Also, such pressure may
come from the same families that afford the most
knowledge of the relevant conditions, mentioned
above, because of daily pressure of living with a
loved one affected with the condition. Nevertheless,
it seems unreasonable to expect complete freedom
from family pressure112; indeed, adults often feel
family pressure regarding the decision to get genetic
testing. However, it is likely more serious in a minor
because of his or her dependent relationship upon
the parents.
● Children’s understanding of inheritance and kin-
ship. Richards117 points out that inheritance and
kinship should not be equated with Mendelian ge-
netics, but with lay concepts of kinship and chil-
dren’s understanding of the relationships and re-
sponsibilities among their family members. He
found that evidence of children’s beliefs about kin-
ship is lacking in the literature, but would be impor-
tant in assessing competence in decision-making
about genetic testing.
● The more general educational context. The context
in which explanations are given to the children also
affects their ability to make informed decisions, e.g.,
how well the experts explaining the facts to them
understand the condition and testing/treatment, and
how new and risky the treatment.112
Psychological Adaptation: Adolescence,
Self-esteem, and Future Protective Barriers
Adolescence is a critical time for the formation of the
concepts of social identity, self-esteem, and personal
worth. Concerns have been raised that knowing a posi-
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tive test result for a future debilitating condition might
well interfere with these natural processes. However,
these concerns need to be balanced against positive
results relevant to the adolescents’ future that have some-
times been found: in some situations, when individuals
are told about a condition such as Huntington’s disease
during adolescence, they appear more able to deal with it
later during their lives than those told during adult-
hood.118 While of course we do not equate Huntington’s
disease with obesity, adolescence may be an important
formative period, and knowledge obtained then may
facilitate development of autonomy119 and buffer indi-
viduals in their later accommodation to their situation.120
This trade-off between adolescents’ developing self-es-
teem and future protection requires further research.
Some authors believe that decisions about some genetic
testing, e.g., for hereditary breast cancer, should be made
by all “psychologically normal” adolescents, because
respect for their autonomous choices has such positive
consequences for their self-esteem.121
Other attributes of adolescents relate to the way that
self-esteem develops during this period and how this
may influence their ability to participate in decisions
about genetic testing. These include pressure to conform
to peer group norms at all costs (although parents often
remain more influential regarding key values)106 and
adolescents’ perceptions of an external locus of control,
which may make them less likely to question received
health-related information.85
Issues Specific to Genetic Testing of Minors
for Obesity
Distinction between Early and Late Onset Is
Frequently Made but Not Simple to Apply
The National Human Genome Research Institute’s Task
Force on Genetic Testing 1997 report, “Promoting Safe
and Effective Genetic Testing in the United States,”
recommended that children not be tested for adult-onset
genetic conditions unless medical interventions existed
that could benefit the children directly.122 Similarly, a
2001 policy statement by the American Academy of
Pediatrics stated that “genetic testing of children and
adolescents to predict late-onset disorders is inappropri-
ate when the genetic information has not been shown to
reduce morbidity and mortality through interventions
initiated in childhood.”123 While the distinction between
early- and late-onset diseases may be useful in evaluating
genetic testing of children for many conditions, obesity is
not so easily categorized. Except for some rare child-
hood-onset conditions, obesity may be either a youth- or
an adult-onset disease, with gradual onset of symptoms.
However, the actual medical conditions that require
treatment (e.g., diabetes or heart disease) are less likely
to occur in youth (although this is changing somewhat).
Thus, obesity may not have the same urgency for treat-
ment as other conditions, e.g., phenylketonuria.
Insurance companies and Medicare do not currently
cover many forms of obesity treatment because it is
usually considered a symptom or precursor to some other
disease, and not worth treating by itself. Until very
recently, taxpayers have not been able to deduct the costs
of weight loss programs as medical expenses unless they
were recommended by a doctor to treat a specific disease.
Obesity itself was not recognized by the IRS as an
ailment that qualified for the weight loss expense deduc-
tion afforded to those with pathology that may be asso-
ciated with obesity. In April 2002, however, the IRS
ruled that obesity itself qualifies as a disease for which
medical treatment is tax-exempt, and this could pave the
way for insurers to cover obesity treatment per se. These
policies may lead to greater public recognition that obe-
sity in minors is an early-onset disease. Especially if
more successful prevention efforts can be found now
than in the past, or if treatments that have broad appli-
cability are discovered, it is likely there will be greater
acceptance of testing minor children for obesity. Re-
search with adolescents is lacking, however, about
whether knowledge of a genetic test result could itself, at
least under some conditions and for some of those
affected, be a deterrent to start or an inducement to
control overeating.
Obesity May Be Accompanied by Social
Stigmatization Not Present in Some Other
Genetic Conditions
The obese are severely stigmatized as self-indulgent,
without self-discipline, lazy, and unattractive,124 and
they believe these stereotypes themselves, leading to
self-prejudice and erosion of self-esteem with no self-
protective strategy to buffer negative feedback.125,126
The social stigma of obesity appears to hold as true for
youths and adolescents as for adults. In laboratory stud-
ies,127–129 obesity in children leads to rejection by peers
and is associated with negative characteristics such as
laziness and sloppiness.130 The evidence in general sug-
gests that overweight children have poorer self-concept
than normal-weight children,131,132 and girls may show
depressive symptoms.133 By adolescence, those who are
overweight develop poor self-esteem134 and a negative
self-image that persists into adulthood135; they are also
more likely to report victimization by peers,136 social
isolation,137 and serious emotional problems.138,139 Both
children and adolescents who are obese report lower
social functioning and psychosocial functioning scores
on health-related quality of life inventories.140 However,
information that shifts the responsibility from the obese
and describes them as not responsible for their condition
may mitigate this stigma in children as young as elemen-
tary school.141 The attenuating effect of the information
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regarding causes of obesity on stigmatization is provoc-
ative, and will be important to explore in future research:
a recent report found that providing information to adults
that obesity is mainly due to genetic factors did not lower
bias.142 In one research study, a majority of adults with
other stigmatizing conditions, such as bipolar disorder,
and their social supporters endorsed genetic testing for
children, even in the absence of treatment, perhaps as a
way to counter stigma and suggest that the problem is not
the fault of affected individuals.143
Suggestions for Research about Genetic
Testing of Adolescents for Obesity
Difficulties in Policy Development
Many variables must be taken into account in research to
develop policy guidelines for genetic testing of adoles-
cents for biobehavioral traits such as obesity. For exam-
ple, demographic subgroups must be considered, because
gender, race/ethnicity, and social class are confounded
with prevalence of and attitudes towards obesity and
genetic testing.
Sub-group differences: gender. Psychological ef-
fects of the highly stigmatizing condition of obesity are
moderated by gender: weight and control of eating ap-
pear to be more serious issues for women than for
men.124,144 In children, the psychosocial effects of obe-
sity appear more severe for girls than for boys,145 who
are less likely to try to lose weight and less concerned
about their weight.146,147 Adolescent obesity in women
(but not in men), as distinct from a variety of other
physical chronic conditions such as asthma, is associated
with lowered social achievement in early adulthood, e.g.,
income and advanced education, even after controlling
for income and education in the family of origin.148
Gender differences have also been noted in genetic
counseling. For example, in cystic fibrosis testing,
women said they were happier than men at being non-
carriers and unhappier at being carriers.68
Sub-group differences: race/ethnicity. The preva-
lence of obesity in African Americans is higher than in
European Americans: in African-American women,
prevalence is estimated at around 37%; more than half
are overweight.149 Psychosocial consequences of obesity
have been observed in Latino children as well as in
African-American and European-American children,134,150
and some studies suggest that Latina women are nega-
tively affected by concerns about body image.151 Poor
self-esteem is correlated more often with high body
weight among European Americans than among African
Americans,152 and obese African-American women ap-
pear less preoccupied with their body image146,147 and
with the social consequences of their obesity.153 There
may be a lower BMI-associated mortality rate in African
Americans relative to European Americans,154 and some
researchers believe that genetic factors may contribute to
observed differences among ethnic groups.155,156 Ethnic
differences have also been noted in genetic testing. For
example, in one study, African-American women given
education and counseling planned to be tested for breast
cancer genetic mutations with greater frequency than
those who received education only, while no differences
were observed for Caucasian women.157
Sub-group differences: social class and cultural as-
pects. The variation among different ethnic groups in
prevalence of obesity is confounded with social class. A
large literature demonstrates the association between
lower social class, defined variously as educational sta-
tus, income, occupational status, or some combination
of these, and higher rates of obesity in the United
States,158–162 Europe,163–169 and elsewhere. The effect is
widely reported in children and adolescents as well as in
adults.
Adults with higher income and educational status
are more likely to perceive themselves as overweight,
relative to lower-income adults with the same BMI.147
Also, mothers of low educational status (high school or
less) tend to fail to perceive that their young (age 2–5
years) children are overweight, after controlling for
child’s age, gender, and race.170 Studies have empha-
sized the importance of cultural factors in the family,
e.g., the amount of physical activity and feeding control
patterns on development of obesity.166,167,171
Large Number of Factors
The review above suggests that the following factors will
need to be taken into account in research to develop
policy and to counsel individual adolescents on obtaining
genetic testing for obesity:
● Family demographics,
● Child’s age,
● Child’s gender,
● Ethnicity,
● Social class (educational status, income), and
● Weight status, e.g., BMI.
In fact, an important question will be whether the
adolescent is obese at the time of testing or at risk
because of the familial history. For each of the following,
both the child’s and the family’s perceptions should be
taken into account:
● Level of stigma experienced for obesity,
● Perceptions of health risks associated with obesity,
● Perceptions of child’s ability to control obesity,
● Anticipated changes in self-concept if a genetic test
result is positive,
● Attitudes about autonomy of children,
● Anticipated approval or disapproval of the support
network,
● Cognitive ability to process the relevant genetic risk
information,
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● Knowledge of obesity based on personal experience,
and
● Understanding of inheritance and kinship.
In most cases, the parents will be the most rele-
vant family members, although siblings, extended
family networks, and/or the child’s guardian may also
be involved.
This is a large number of complex factors. Further-
more, they do not include any of the variables associated
with a genetic counselor (e.g., the counselor’s beliefs
about the family or the trait or the counselor’s need for
certainty or external/internal locus of control), but surely
counselors vary on these, and they will need to be taken
into account in any model of shared decision-making
between patients and counselors.
Communication, Always Important, Is Critical
Here
Many authors have noted the importance of communi-
cation in counseling for genetic testing, and have stressed
informed consent as a process rather than a single
event.172 This process should involve a transaction be-
tween all parties rather than expert advice that flows
unidirectionally from counselor to patient, although au-
thors point out the difficulties in applying this to mi-
nors.173 In this context, tailored print communication,
developed especially for an individual on the basis of
knowledge about his or her circumstances, may be use-
ful.174 Audiences appear to interpret the meaning of
terms such as “mutation” and “risk” differently from
what is meant by authors of these messages, and so it will
be very important to pre-test messages; few studies
integrate communication research with the genetic con-
text.173
A good example of ways in which a patient’s indi-
vidual cognitive style may interact with message type is
found in Croyle et al.’s 1995 study,175 which showed an
interaction between need for certainty and type of infor-
mation presented in predicting individuals’ interest in
genetic testing. People with a high need for certainty
were more interested in genetic testing when provided a
standard description rather than a more complete de-
scription of how to interpret population-based genetic
risk for a negative test; those with low need for certainty
showed the opposite pattern. Personal perception of the
kind of information provided by a test is an important
predictor of future use of the test. Effective communica-
tion will be very important in dealing with adolescents
and biobehavioral traits such as obesity, because of the
socially sensitive nature of the behavior, issues of per-
sonal responsibility, and the adolescent’s stage of devel-
opment of self-esteem.
The Public Health Arena as a Focus for
Educational Efforts
All of the foregoing suggests great complexity in the
issues surrounding genetic testing of adolescents for
obesity. Will the providers of counseling efforts for
genetic testing be ready for this job? Genetic counselors
are in short supply, and primary care providers—general
practitioners and pediatricians—are currently not well-
trained in genetic counseling generally.176–179
Unless the financial regulations change for delivery
of genetic counseling services, it seems doubtful that
individual counselors will be available, or reimbursed,
for in-depth counseling of adolescents and their families
on genetic testing for widely prevalent biobehavioral
traits such as obesity. Yet these issues will be of serious
concern when genetic bases for obesity are identified and
tests are available, particularly because tests often
emerge into the marketplace before their best use is
clearly defined. Schools, workplaces, the mass media,
and individualized technologic education programs that
use interactive surveys and guidelines all have the po-
tential to be tremendously useful resources that can be
efficiently mobilized to help educate consumers about
genetic testing of adolescents for obesity.
These recommendations assume that general, widely
applicable guidelines will be difficult to develop and
even more difficult to deliver because:
. . . each child, and each child-parent relationship, is
unique. There is a limit to how helpful general ideas
can be when talking with the individual child—so
much depends on the specific relationship and on how
freely and comfortably the child and adult talk about
many other things. It may be assumed that parents
should have an orderly plan, gradually unfolding
information as the child ‘develops,’ but life is not like
that. Some children understand something long before
the textbooks say that they can, others want to talk
years after that ‘stage’. . . . There are barriers to
communication, especially in busy clinics. . . . Com-
munication goes beyond words in tone of voice . . . fa-
cial expression and body language. . . . More impor-
tant than practical barriers are those of attitudes . . . .112
This will be very difficult for the genetic counselor to
assess in the time available for individual counseling.
Not only children but also adults will need exposure
to public education efforts about the basic concepts of
genetics, risk, and probability.48 Genetic literacy is crit-
ical for the coming age of widely available genetic
testing. One expert suspects that “as the range of tests
that are commercially available continues to grow,
within a global economy where information is freely
available to those with access to the Web, it is going to
314 Nutrition Reviews, Vol. 62, No. 8
be increasingly difficult to prevent anyone from having
tests performed on any DNA sample, whether it comes
from an adult or a child.”117
We may infer from the literature on medical deci-
sion-making that mid-adolescence may be a time when
appropriately educated adolescents can understand the
issues involved in such testing and give informed con-
sent, although little work has examined this question
directly. With broad media exposure, the public appears
to be approaching an understanding that obesity is a
disease in its own right that needs to be prevented and/or
treated, and that this is a better alternative than waiting
until an individual becomes symptomatic for diseases for
which obesity is a risk factor. One aspect that will be
crucial in future discussions of genetic testing for biobe-
havioral traits such as obesity is whether effective pre-
vention strategies and behavioral and genetic-based
treatments exist. This will have an important effect on
the advantages and disadvantages of genetic testing for
obesity at specific ages. We cannot predict this in ad-
vance, but we can begin to address issues of numeracy
and scientific literacy, particularly regarding risk and
probability, which have implications not only for genetic
testing of obesity, but also for genetic testing in general,
as well as understanding the risks of many diseases and
treatments. As the consumer decision-making movement
continues to grow, this will be extremely important
across a wide variety of situations in health care.
We can also begin to understand the best ways to
frame the issues in genetic testing for affected youths.
Such genetic testing might be widely approved and taken
up by parents and affected youths because of the possible
relief from stigma and personal responsibility it might
provide. Our group is beginning to address these issues
systematically with focus groups and in-depth interviews
of adults, adolescents, and parents of younger children.
We recognize that interest in hypothetical testing has
been shown to be a poor predictor of uptake when tests
later became available, e.g., for diseases such as Hun-
tington’s disease and breast cancer. However, it is criti-
cal not to wait until tests actually become available to
formulate the issues and to begin to address them, be-
cause experience shows that when a widely desired
health care option becomes possible, time is inadequate
between its initial availability and subsequent uptake to
do the careful research that is required.
Would a positive genetic test result in more respon-
sible health care practices to guard against obesity
among affected or at-risk adolescents? At this point, we
cannot predict this, as to our knowledge no research has
been published with subjects in this age group. However,
we can ask adolescents and their parents today to share
ideas about this with us. We suspect that such research is
likely to be more successful if subjects are asked to
suggest not simply whether they would or would not
adhere to improved health regimens, but rather the con-
ditions under which they would or would not, and the
reasons why the conditions might yield different results.
This approach will yield testable hypotheses at the time
that genetic testing becomes available.
Our suggestions that we anticipate using community
settings to deliver educational interventions to adoles-
cents and their families regarding genetic testing for
obesity, and that we begin to develop interactive, per-
sonally tailored mechanisms to do so, are similar to
recommendations by Marcus for risk communication for
cancer.180 In this way, we can hope to maximize adoles-
cents’ autonomy within the wider context of the needs of
their families for guidance and control. We can help
them to obtain tools for understanding and communicat-
ing about these sensitive and important issues, and so
maximize the usefulness to individuals of the new ge-
netic technologies that will emerge.
Research determining the content of these types of
educational strategies is needed. As Marcus has pointed
out, “What is not fully understood is the role of socio-
cultural norms, and by extension, various significant
others (and especially the family) in modifying or medi-
ating risk communication on individual health behav-
ior. . . . Similarly, we lack a basic understanding of how
individual risk information might impact the family,
including familial relationships and the risk perceptions
of other family members.”180 Research in these areas,
with the goal of the eventual development of widely
available but personalized public health educational ef-
forts, will be an important start in responsibly addressing
the enormous potential of genetic technology for biobe-
havioral traits such as obesity.
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